PNC Financial Services Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $642 | Buy |
+49
| New | +$642 | ﹤0.01% | 4641 |
|
|
2024
Q2 | – | Sell |
-4
| Closed | -$73 | – | 4795 |
|
|
2024
Q1 | $73 | Sell |
4
-6
| -60% | -$110 | ﹤0.01% | 4652 |
|
|
2023
Q4 | $109 | Buy |
+10
| New | +$109 | ﹤0.01% | 4515 |
|
|
2023
Q2 | – | Sell |
-202
| Closed | -$1.35K | – | 4772 |
|
|
2023
Q1 | $1.35K | Hold |
202
| – | – | ﹤0.01% | 4384 |
|
|
2022
Q4 | $1.81K | Hold |
202
| – | – | ﹤0.01% | 4289 |
|
|
2022
Q3 | $2K | Sell |
202
-128
| -39% | -$1.27K | ﹤0.01% | 4170 |
|
|
2022
Q2 | $2K | Buy |
+330
| New | +$2K | ﹤0.01% | 4192 |
|